|
Originally published In Press as doi:10.1074/jbc.M004392200 on October 5, 2000
J. Biol. Chem., Vol. 276, Issue 1, 40-47, January 5, 2001
L-Ascorbic Acid Potentiates Endothelial Nitric Oxide
Synthesis via a Chemical Stabilization of Tetrahydrobiopterin*
Regine
Heller §,
Anett
Unbehaun,
Berit
Schellenberg,
Bernd
Mayer¶,
Gabriele
Werner-Felmayer , and
Ernst R.
Werner
From the Center of Vascular Biology and Medicine,
Friedrich-Schiller-University of Jena, D-99089 Erfurt, Germany, the
¶ Institute for Pharmacology and Toxicology,
Karl-Franzens-University, A-8010 Graz, Austria, and the
Institute for Medical Chemistry and Biochemistry, University of
Innsbruck, A-6020 Innsbruck, Austria
Ascorbic acid has been shown to
stimulate endothelial nitric oxide (NO) synthesis in a time- and
concentration-dependent fashion without affecting NO
synthase (NOS) expression or L-arginine uptake. The
present study investigates if the underlying mechanism is related to
the NOS cofactor tetrahydrobiopterin. Pretreatment of human umbilical
vein endothelial cells with ascorbate (1 µM to 1 mM, 24 h) led to an up to 3-fold increase of
intracellular tetrahydrobiopterin levels that was
concentration-dependent and saturable at 100 µM.
Accordingly, the effect of ascorbic acid on
Ca2+-dependent formation of citrulline
(co-product of NO) and cGMP (product of the NO-activated soluble
guanylate cyclase) was abolished when intracellular tetrahydrobiopterin
levels were increased by coincubation of endothelial cells with
sepiapterin (0.001-100 µM, 24 h). In contrast,
ascorbic acid did not modify the pterin affinity of endothelial NOS,
which was measured in assays with purified tetrahydrobiopterin-free
enzyme. The ascorbate-induced increase of endothelial
tetrahydrobiopterin was not due to an enhanced synthesis of the
compound. Neither the mRNA expression of the rate-limiting enzyme
in tetrahydrobiopterin biosynthesis, GTP cyclohydrolase I, nor the
activities of either GTP cyclohydrolase I or
6-pyruvoyl-tetrahydropterin synthase, the second enzyme in the de
novo synthesis pathway, were altered by ascorbate. Our data
demonstrate that ascorbic acid leads to a chemical stabilization of
tetrahydrobiopterin. This was evident as an increase in the half-life
of tetrahydrobiopterin in aqueous solution. Furthermore, the increase
of tetrahydrobiopterin levels in intact endothelial cells coincubated
with cytokines and ascorbate was associated with a decrease of more
oxidized biopterin derivatives (7,8-dihydrobiopterin and biopterin) in
cells and cell supernatants. The present study suggests that saturated
ascorbic acid levels in endothelial cells are necessary to protect
tetrahydrobiopterin from oxidation and to provide optimal conditions
for cellular NO synthesis.
*
This work was supported by a grant from the Verbund
für klinische Forschung, Klinikum der
Friedrich-Schiller-Universität Jena (to R. H.) and by
Austrian research funds "Zur Förderung der wissenschaftlichen
Forschung" Project 13793-MOB (to E. R. W.) and Project
P13586-MED (to B. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Center of Vascular
Biology and Medicine, Friedrich-Schiller-University of Jena, Nordhäuser Str. 78, 99089 Erfurt, Germany. Tel.: 49-361-741-1437; Fax: 49-361-741-1103; E-mail:
heller@zmkh.ef.uni-jena.de.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Peluffo, P. Calcerrada, L. Piacenza, N. Pizzano, and R. Radi
Superoxide-mediated inactivation of nitric oxide and peroxynitrite formation by tobacco smoke in vascular endothelium: studies in cultured cells and smokers
Am J Physiol Heart Circ Physiol,
June 1, 2009;
296(6):
H1781 - H1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Thomson, M. P. Frenneaux, and J. C. Kaski
Antioxidant treatment for heart failure: friend or foe?
QJM,
May 1, 2009;
102(5):
305 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Kirby, W. F. Voyles, C. B. Simpson, R. E. Carlson, W. G. Schrage, and F. A. Dinenno
Endothelium-dependent vasodilatation and exercise hyperaemia in ageing humans: impact of acute ascorbic acid administration
J. Physiol.,
May 1, 2009;
587(9):
1989 - 2003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Perrier, M.-P. Fournet-Bourguignon, E. Royere, S. Molez, H. Reure, L. Lesage, W. Gosgnach, Y. Frapart, J.-L. Boucher, N. Villeneuve, et al.
Effect of uncoupling endothelial nitric oxide synthase on calcium homeostasis in aged porcine endothelial cells
Cardiovasc Res,
April 1, 2009;
82(1):
133 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Schmitt, E. H. Heiss, Y. Aristei, T. Severin, and V. M. Dirsch
Norfuraneol dephosphorylates eNOS at threonine 495 and enhances eNOS activity in human endothelial cells
Cardiovasc Res,
March 1, 2009;
81(4):
750 - 757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li and H. E. Schellhorn
New Developments and Novel Therapeutic Perspectives for Vitamin C
J. Nutr.,
October 1, 2007;
137(10):
2171 - 2184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. T. Gao, L. J. Roman, P. Martasek, S. P. Panda, Y. Ishimura, and B. S. S. Masters
Oxygen Metabolism by Endothelial Nitric-oxide Synthase
J. Biol. Chem.,
September 28, 2007;
282(39):
28557 - 28565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Holowatz and W. L. Kenney
Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans
Am J Physiol Heart Circ Physiol,
August 1, 2007;
293(2):
H1090 - H1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fukai
Endothelial GTPCH in eNOS Uncoupling and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2007;
27(7):
1493 - 1495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Holowatz, C. S. Thompson, and W. L. Kenney
Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin
Am J Physiol Heart Circ Physiol,
December 1, 2006;
291(6):
H2965 - H2970.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Moens and D. A. Kass
Tetrahydrobiopterin and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2006;
26(11):
2439 - 2444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Stahmann, A. Woods, D. Carling, and R. Heller
Thrombin Activates AMP-Activated Protein Kinase in Endothelial Cells via a Pathway Involving Ca2+/Calmodulin-Dependent Protein Kinase Kinase {beta}.
Mol. Cell. Biol.,
August 1, 2006;
26(16):
5933 - 5945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.M. Saed, M. Zhao, M.P. Diamond, and H.M Abu-Soud
Regulation of inducible nitric oxide synthase in post-operative adhesions
Hum. Reprod.,
June 1, 2006;
21(6):
1605 - 1611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yang and X.-F. Ming
Recent advances in understanding endothelial dysfunction in atherosclerosis.
Clin. Med. Res.,
March 1, 2006;
4(1):
53 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Z. Sheng, D. Wang, and A. P. Braun
DAF-FM (4-Amino-5-methylamino-2',7'-difluorofluorescein) Diacetate Detects Impairment of Agonist-Stimulated Nitric Oxide Synthesis by Elevated Glucose in Human Vascular Endothelial Cells: Reversal by Vitamin C and L-Sepiapterin
J. Pharmacol. Exp. Ther.,
November 1, 2005;
315(2):
931 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Heiss, P. Kleinbongard, A. Dejam, S. Perre, H. Schroeter, H. Sies, and M. Kelm
Acute Consumption of Flavanol-Rich Cocoa and the Reversal of Endothelial Dysfunction in Smokers
J. Am. Coll. Cardiol.,
October 4, 2005;
46(7):
1276 - 1283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mittermayer, J. Pleiner, G. Schaller, S. Zorn, K. Namiranian, S. Kapiotis, G. Bartel, M. Wolfrum, M. Brugel, J. Thiery, et al.
Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction
Am J Physiol Heart Circ Physiol,
October 1, 2005;
289(4):
H1752 - H1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Thoeni, P. Stoitzner, G. Brandacher, N. Romani, C. Heufler, G. Werner-Felmayer, and E. R. Werner
Tetrahydro-4-Aminobiopterin Attenuates Dendritic Cell-Induced T Cell Priming Independently from Inducible Nitric Oxide Synthase
J. Immunol.,
June 15, 2005;
174(12):
7584 - 7591.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Erwin, A. J. Lin, D. E. Golan, and T. Michel
Receptor-regulated Dynamic S-Nitrosylation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
J. Biol. Chem.,
May 20, 2005;
280(20):
19888 - 19894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. McKee, S. J Moat, and I. McDowell
Statins and micronutrients: unanswered questions
J R Soc Med,
October 1, 2004;
97(10):
459 - 460.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stocker and J. F. Keaney Jr.
Role of Oxidative Modifications in Atherosclerosis
Physiol Rev,
October 1, 2004;
84(4):
1381 - 1478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Clapp, A. D. Hingorani, R. K. Kharbanda, V. Mohamed-Ali, J. W. Stephens, P. Vallance, and R. J. MacAllister
Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress
Cardiovasc Res,
October 1, 2004;
64(1):
172 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Moat, S. N. Doshi, D. Lang, I. F. W. McDowell, M. J. Lewis, and J. Goodfellow
Treatment of coronary heart disease with folic acid: is there a future?
Am J Physiol Heart Circ Physiol,
July 1, 2004;
287(1):
H1 - H7.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Sharma, S. A.V. Raghavan, R. Saini, and M. Dikshit
Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide
J. Leukoc. Biol.,
June 1, 2004;
75(6):
1070 - 1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kawashima and M. Yokoyama
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2004;
24(6):
998 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M C Verhaar, P E Westerweel, A J van Zonneveld, and T J Rabelink
Free radical production by dysfunctional eNOS
Heart,
May 1, 2004;
90(5):
494 - 495.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vergely, F. Goirand, A. Ecarnot-Laubriet, C. Renard, D. Moreau, J.-C. Guilland, M. Dumas, and L. Rochette
Vitamin C Deficiency Exerts Paradoxical Cardiovascular Effects in Osteogenic Disorder Shionogi (ODS) Rats
J. Nutr.,
April 1, 2004;
134(4):
729 - 735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. S. Katusic and L. V. d'Uscio
Tetrahydrobiopterin: Mediator of Endothelial Protection
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2004;
24(3):
397 - 398.
[Full Text]
|
 |
|

|
 |

|
 |
 
N. J. Alp and K. M. Channon
Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease
Arterioscler. Thromb. Vasc. Biol.,
March 1, 2004;
24(3):
413 - 420.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Kinlay, D. Behrendt, J. C. Fang, D. Delagrange, J. Morrow, J. L. Witztum, N. Rifai, A. P. Selwyn, M. A. Creager, and P. Ganz
long-term effect of combined vitamins e and c on coronary and peripheral endothelial function
J. Am. Coll. Cardiol.,
February 18, 2004;
43(4):
629 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mak and G. E. Newton
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure
Am J Physiol Heart Circ Physiol,
February 1, 2004;
286(2):
H789 - H795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Nightingale, M. Schmitt, M. P. Frenneaux, G. Piccirillo, M. Nocco, A. Moise, M. Lionetti, C. Naso, and S. D. C. V. Marigliano
Letter: Vitamin C in Heart Failure: Hype or Hope?
Hypertension,
February 1, 2004;
e6(2):
.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Werner, A. C.F. Gorren, R. Heller, G. Werner-Felmayer, and B. Mayer
Tetrahydrobiopterin and Nitric Oxide: Mechanistic and Pharmacological Aspects
Experimental Biology and Medicine,
December 1, 2003;
228(11):
1291 - 1302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Schindler, E. U. Nitzsche, T. Munzel, M. Olschewski, I. Brink, M. Jeserich, M. Mix, P. T. Buser, M. Pfisterer, U. Solzbach, et al.
Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: Contrasting myocardial blood flow responses to short- and long-term vitamin C administration
J. Am. Coll. Cardiol.,
September 3, 2003;
42(5):
814 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Engler, M. B. Engler, M. J. Malloy, E. Y. Chiu, M. C. Schloetter, S. M. Paul, M. Stuehlinger, K. Y. Lin, J. P. Cooke, J. D. Morrow, et al.
Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial
Circulation,
September 2, 2003;
108(9):
1059 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsumoto, L. V. d'uscio, D. Eguchi, M. Akiyama, L. A. Smith, and Z. S. Katusic
Protective Effect of Chronic Vitamin C Treatment on Endothelial Function of Apolipoprotein E-Deficient Mouse Carotid Artery
J. Pharmacol. Exp. Ther.,
July 1, 2003;
306(1):
103 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Wu, J. X. Wilson, and K. Tyml
Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice
Am J Physiol Regulatory Integrative Comp Physiol,
July 1, 2003;
285(1):
R50 - R56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov
Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols: IMPLICATIONS FOR UNCOUPLING ENDOTHELIAL NITRIC-OXIDE SYNTHASE
J. Biol. Chem.,
June 13, 2003;
278(25):
22546 - 22554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Anderson, J. Hubacek, D. G. Wyse, and M. L. Knudtson
Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy
J. Am. Coll. Cardiol.,
February 5, 2003;
41(3):
420 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K Dutta, et al.
Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
J. Am. Coll. Nutr.,
February 1, 2003;
22(1):
18 - 35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hattori, N. Nakanishi, K. Akimoto, M. Yoshida, and K. Kasai
HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2003;
23(2):
176 - 182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. d'Uscio, S. Milstien, D. Richardson, L. Smith, and Z. S. Katusic
Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity
Circ. Res.,
January 10, 2003;
92(1):
88 - 95.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Tarpey
Sepiapterin Treatment in Atherosclerosis
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2002;
22(10):
1519 - 1521.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vasquez-Vivar, D. Duquaine, J. Whitsett, B. Kalyanaraman, and S. Rajagopalan
Altered Tetrahydrobiopterin Metabolism in Atherosclerosis: Implications for Use of Oxidized Tetrahydrobiopterin Analogues and Thiol Antioxidants
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2002;
22(10):
1655 - 1661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
Vascular Medicine,
August 1, 2002;
7(3):
213 - 225.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Woo, J. Y. Kang, Y. K. Choi, and Y. S. Park
Production of Sepiapterin in Escherichia coli by Coexpression of Cyanobacterial GTP Cyclohydrolase I and Human 6-Pyruvoyltetrahydropterin Synthase
Appl. Envir. Microbiol.,
June 1, 2002;
68(6):
3138 - 3140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Hyndman, S. Verma, R. J. Rosenfeld, T. J. Anderson, and H. G. Parsons
Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function
Am J Physiol Heart Circ Physiol,
June 1, 2002;
282(6):
H2167 - H2172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Werner, S. Bahrami, R. Heller, and G. Werner-Felmayer
Bacterial Lipopolysaccharide Down-regulates Expression of GTP Cyclohydrolase I Feedback Regulatory Protein
J. Biol. Chem.,
March 15, 2002;
277(12):
10129 - 10133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Toth, Z. Kukor, and S. Valent
Chemical stabilization of tetrahydrobiopterin by L-ascorbic acid: contribution to placental endothelial nitric oxide synthase activity
Mol. Hum. Reprod.,
March 1, 2002;
8(3):
271 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.C. Verhaar, E. Stroes, and T.J. Rabelink
Folates and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2002;
22(1):
6 - 13.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gori, J. M. Burstein, S. Ahmed, S. E.S. Miner, A. Al-Hesayen, S. Kelly, and J. D. Parker
Folic Acid Prevents Nitroglycerin-Induced Nitric Oxide Synthase Dysfunction and Nitrate Tolerance: A Human In Vivo Study
Circulation,
September 4, 2001;
104(10):
1119 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. S. Katusic
Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?
Am J Physiol Heart Circ Physiol,
September 1, 2001;
281(3):
H981 - H986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Huang, H. Xiao, J. M. Samii, J. A. Vita, and J. F. Keaney Jr.
Contrasting effects of thiol-modulating agents on endothelial NO bioactivity
Am J Physiol Cell Physiol,
August 1, 2001;
281(2):
C719 - C725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. W. M. van Hinsbergh
NO or H2O2 for Endothelium-Dependent Vasorelaxation : Tetrahydrobiopterin Makes the Difference
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2001;
21(5):
719 - 721.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nuszkowski, R. Grabner, G. Marsche, A. Unbehaun, E. Malle, and R. Heller
Hypochlorite-modified Low Density Lipoprotein Inhibits Nitric Oxide Synthesis in Endothelial Cells via an Intracellular Dislocalization of Endothelial Nitric-oxide Synthase
J. Biol. Chem.,
April 20, 2001;
276(17):
14212 - 14221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Hyndman, S. Verma, R. J. Rosenfeld, T. J. Anderson, and H. G. Parsons
Interaction of 5-methyltetrahydrofolate and tetrahydrobiopterin on endothelial function
Am J Physiol Heart Circ Physiol,
June 1, 2002;
282(6):
H2167 - H2172.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|